跳至主要内容
临床试验/NCT05052203
NCT05052203Enrolling By Invitation不适用

Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis (REQOVERY)

Hjalmar Bouma1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
120
试验地点
1
主要终点
DNA methylation (epigenetics) using the Illumina MethylationEPIC kit. Changes in DNA methylation at gene promoter/enhancer sites will be correlated through the NetworkAnalyst platform.

研究概览

简要总结

Sepsis is a life-threatening dysregulated immune response to infection associated with multi-organ failure and a high mortality rate.While researchers have focused mainly on acute sepsis, post-sepsis care of survivors has long been neglected despite the observation that many sepsis survivors suffer from debilitating post-sepsis syndrome. This syndrome is characterized by frequent hospital readmissions and increased mortality due to persistent immune dysfunction, cardiovascular disease, and cognitive impairment, causing poor quality of life and a substantial burden on the healthcare system. Disconcertingly, the number of sepsis survivors at risk for hospital readmission continues to rise.7 Of the post-sepsis symptoms, post-sepsis immunosuppression is perhaps the most clinically important. While sepsis presents as an initial phase of hyperinflammation (a "cytokine storm"), it is followed by an immunosuppressive phase that is now understood to last weeks to months and predisposes survivors to lethal secondary infections and sepsis recurrence. A third of deaths eight years post-sepsis are caused by recurrent sepsis.We hypothesize that changes in the transcriptome and DNA methylome in immune cells of survivors might be the underlying driver for prolonged immunosuppression, and may also be correlated with long-term morbidity and mortality post-sepsis, as well as other symptoms of post-sepsis syndrome including PTSD and cardiovascular disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

DNA methylation (epigenetics) using the Illumina MethylationEPIC kit. Changes in DNA methylation at gene promoter/enhancer sites will be correlated through the NetworkAnalyst platform.

时间窗: baseline versus 3 months follow up

The primary objective of the current project is to measure changes in DNA methylation (i.e. epigenetics) of blood leukocytes between sepsis survivors at ED admission and three months after hospital discharge.

Gene expression (transcriptomics/qPCR) will be measured using the Illumina Hi-Seq instrument. Differential gene expression will be correlated through the NetworkAnalyst platform.

时间窗: baseline versus 3 months follow up

The primary objective of the current project is to measure changes in gene expression (i.e. transcriptomics) of blood leukocytes between sepsis survivors at ED admission and three months after hospital discharge.

次要结局

  • Mortality. Mortality status will be obtained from the Municipal Personal Records Database (BRP), containing reliable and complete registration all Dutch citizens(1 year)
  • Intoxications(3 months)
  • Medication use(3 months)
  • Physical activity (e.g. Short Questionnaire to Assess Health-Enhancing Activity) (SQUASH) and 'Utrechtse activiteiten lijst' (UAL))(3 months)
  • Nutrition status measured with PS-SGA Short Form and SNAQ form. (both questionnaires)(3 months)
  • Sepsis severity defined with SOFA score(3 months follow up)
  • Somatic symptoms (e.g. Patient Health questionnaire-15)(3 months)
  • Activities of daily living as determined by EQ-5D-5L (if abnormal also Katz-ADL-6)(3 months)
  • Co-morbidity (a.o. Charlson comorbidity index)(3 months)
  • Length-of-stay in hospital/intensive care unit (ICU)(0-3 months)
  • Fatigue assessed with piper fatigue scale(3 months)
  • Mood assessed with the Patient Health Questionnaire-2 ( (questionnaire)(3 months)
  • Demographics(3 months)
  • Vital parameters(At baseline and three months.)

研究者

发起方
Hjalmar Bouma
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hjalmar Bouma

Internist and Research Fellow

University Medical Center Groningen

研究点 (1)

Loading locations...

相似试验

Researching the Effects of Sepsis on Quality Of... | 临床试验